Home background delphi consensus BASIL audit survival predictor personnel trial forms links publications

 

BASIL Trial Publications

The BASIL Trial outputs have been published in the form of peer reviewed manuscripts in scientific journals.

In addition, an executive summary and a full trial report can be found on the HTA website

 

2002

European Journal of Vascular & Endovascular Surgery. 24(5):411-6, 2002 Nov

Bypass or angioplasty for severe limb ischaemia? A Delphi Consensus Study.

Bradbury AW. Bell J. Lee AJ. Prescott RJ. Gillespie I. Stansby G. Fowkes FG.

 

2004

Journal of Vascular Surgery. 39(5):1026-32, 2004 May

Bypass versus angioplasty to treat severe limb ischemia: factors that affect treatment preferences of UK surgeons and interventional radiologists

Bradbury A. Wilmink T. Lee AJ. Bell J. Prescott R. Gillespie I. Stansby G. Fowkes FG.

 

2005

The Lancet 2005 Dec 3;366(9501):1925-34

Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial

 

2009

Seminars in Vascular Surgery. Lower Extremity Vein Bypass: Current Status 22:267-274 (2009)

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) Trial: What Are Its Implications?

Andrew W. Bradbury, BSc, MD, MBA, FRCSEd

 

2010

Journal of Vascular Surgery Volume 51, Issue 5, Supplement (May 2010)

Final Results of the BASIL Trial (Bypass Versus Angioplasty in Severe Ischaemia of the Leg) Edited by Andrew W. Bradbury

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial in perspective
Andrew W. Bradbury, BASIL trial Investigators and Participants

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy
Andrew W. Bradbury, Donald J. Adam, Jocelyn Bell, John F. Forbes, F. Gerry R. Fowkes, Ian Gillespie, Charles Vaughan Ruckley, Gillian M. Raab, BASIL trial Participants

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received
Andrew W. Bradbury, Donald J. Adam, Jocelyn Bell, John F. Forbes, F. Gerry R. Fowkes, Ian Gillespie, Charles Vaughan Ruckley, Gillian M. Raab, BASIL trial Participants  

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A description of the severity and extent of disease using the Bollinger angiogram scoring method and the TransAtlantic Inter-Society Consensus II classification
Andrew W. Bradbury, Donald J. Adam, Jocelyn Bell, John F. Forbes, F. Gerry R. Fowkes, Ian Gillespie, Charles Vaughan Ruckley, Gillian M. Raab, BASIL trial Participants

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis
John F. Forbes, Donald J. Adam, Jocelyn Bell, F. Gerry R. Fowkes, Ian Gillespie, Gillian M. Raab, Charles Vaughan Ruckley, Andrew W. Bradbury, BASIL trial Participants

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision making
Andrew W. Bradbury, Donald J. Adam, Jocelyn Bell, John F. Forbes, F. Gerry R. Fowkes, Ian Gillespie, Charles Vaughan Ruckley, Gillian M. Raab, BASIL trial Participants

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia
Michael S. Conte